Cytokinetics, Inc. (CYTK) reported fourth-quarter net loss of $12.5 million wider than $10.9 million in the prior year period. On a per share basis, net loss was $0.21, narrower than $0.22 in the same quarter last year.
Revenues for the quarter decreased to $1.0 million from $3.2 million in the previous year period.
On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.22 per share on revenues of $2.90 million for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.